Minimally invasive treatment for osteonecrosis of the femoral head with angioconductive bioceramic rod
- 38 Downloads
To describe the rationale, the surgical technique, and the short-term follow-up results of a new minimally invasive treatment of osteonecrosis of the femoral head (ONFH) with an angioconductive bioceramic rod (ABR) implant.
Sixty-two patients (72 hips) with ARCO stage IIA-IIIC ONFH treated with the minimally invasive ABR from January 2012 to December 2016 were reviewed (17 females, 45 males, mean age 44.49). This technique used the angioconductive properties of the porous implant to repair the necrosis by driving vascularization from the trochanter to the necrotic area. Patients had a mean follow-up period of 26.74 months. The outcomes were evaluated by hip joint survival, radiograph, and the Harris Hip Score (HHS). The complications occurred during the treatment period were recorded.
No serious post-operative complications occurred during the treatment. The overall joint survival rate was 90.27%, with seven conversions to THA. Improvements were observed in 23 (31.95%) hips, 24 (33.33%) hips remained stable, and 25 (34.72%) hips had worse results according to the radiographic evaluation. The mean HHS at the end follow-up significantly improved compared to the pre-operative mean HHS (82.27 vs 58.14, p < 0.001). In both radiographic evaluation and HHS, the treatment was more effective on patients beneath 44 years old (p < 0.05); ARCO stage II compared to stage III (p < 0.05); and China-Japan Friendship Hospital (CJFH) type C compared to CJFH type L (p < 0.05).
The minimally invasive treatment of ONFH with ABR showed promising results in delaying or even terminating the progression of the necrosis and improving hip function, especially in younger patients and in the early stages of the disease.
KeywordsOsteonecrosis Femoral head Hip-preserving Bioceramics Angioconduction
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Liu TG, Chen WH (2009) Research progress of epidemiology about non-traumatic osteonecrosis of femoral head. Med Recapitulate 15(17):2637–2639Google Scholar
- 5.Atsumi T, Kuroki Y (1992) Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin Orthop Relat Res 277(277):22–30Google Scholar
- 10.Xiao X, Wang W, Liu D et al (2015) The promotion of angiogenesis induced by three-dimensional porous beta-tricalcium phosphate scaffold with different interconnection sizes via activation of PI3K/Akt pathways. Sci Rep-UK 5(1):1–11Google Scholar
- 11.Li ZR, Liu ZH, Sun W et al (2012) The classification of osteonecrosis of the femoral head based on the three pillars structure: China-Japan Friendship Hospital (CJFH) classification. Chin J Orthop 32(6):515–520Google Scholar
- 14.Mont MA, Etienne G, Ragland PS (2003) Outcome of nonvascularized bone grafting for osteonecrosis of the femoral head. Clin Orthop Relat Res 417(417):84–92Google Scholar
- 17.Crnogorac-Jurcevic T, Chelala C, Barry S et al (2013) Porous tantalum rod in treating early-stage avascular necrosis of the femoral head: application and issues. Chin J Tissue Eng Res 17(52):9062–9068Google Scholar